Article
Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.
PloS one - 1 Jan 2014
Jujić Amra, Nilsson Peter M, Engström Gunnar, Hedblad Bo, Melander Olle, Magnusson Martin
Abstract excerpt
BACKGROUND: We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
